{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:17:37Z","timestamp":1789654657223,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.vaccine.2004.08.010","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T17:03:33Z","timestamp":1095181413000},"page":"S9-S14","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S1","title":["Host\u2013pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development"],"prefix":"10.1016","volume":"22","author":[{"given":"Thomas","family":"Areschoug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha","family":"St\u00e5lhammar-Carlemalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.08.010_bib1","series-title":"Streptococcal infections. Clinical aspects, microbiology and molecular pathogenesis","year":"2000"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.010_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of Streptococcus haemolyticus. I. Demonstration of a type-specific substance in extracts of Streptococcus haemolyticus","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.010_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","article-title":"Streptococcal M protein: molecular design and biological behavior","volume":"2","author":"Fischetti","year":"1989","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.010_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/07853890252953464","article-title":"Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci","volume":"34","author":"Courtney","year":"2002","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1462-5822.2000.00050.x","article-title":"Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection","volume":"2","author":"Ashbaugh","year":"2000","journal-title":"Cell Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.010_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/324621","article-title":"Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124","volume":"34","author":"Facklam","year":"2002","journal-title":"Clin Infect Dis."},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.010_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.110.2.271","article-title":"Persistence of type-specific antibodies in man following infection with group A streptococci","volume":"110","author":"Lancefield","year":"1959","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.010_bib8","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.4049\/jimmunol.157.7.3021","article-title":"A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP","volume":"157","author":"Johnsson","year":"1996","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.010_bib9","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.4049\/jimmunol.167.7.3870","article-title":"Isolated hypervariable regions derived from streptococcal m proteins specifically bind human C4b-binding protein: implications for antigenic variation","volume":"167","author":"Morfeldt","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.010_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.148.1.207","article-title":"Human C4-binding protein. I. Isolation and characterization","volume":"148","author":"Scharfstein","year":"1978","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1084\/jem.148.4.1044","article-title":"Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator","volume":"148","author":"Fujita","year":"1978","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.010_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.154.1.375","article-title":"Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system","volume":"154","author":"Thern","year":"1995","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.010_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20030543","article-title":"Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein","volume":"198","author":"Carlsson","year":"2003","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.010_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2958.2001.02664.x","article-title":"Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes","volume":"42","author":"Bergg\u00e5rd","year":"2001","journal-title":"Mol Microbiol"},{"issue":"21","key":"10.1016\/j.vaccine.2004.08.010_bib15","doi-asserted-by":"crossref","first-page":"14521","DOI":"10.1074\/jbc.274.21.14521","article-title":"An IgA-binding peptide derived from a streptococcal surface protein","volume":"274","author":"Johnsson","year":"1999","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.vaccine.2004.08.010_bib16","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1074\/jbc.M009396200","article-title":"Streptococcal IgA-binding proteins bind in the C\u03b12\u2013C\u03b13 interdomain region and inhibit binding of IgA to human CD89","volume":"276","author":"Pleass","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.010_bib17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1084\/jem.167.3.1114","article-title":"The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci","volume":"167","author":"Jones","year":"1988","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.010_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4049\/jimmunol.169.3.1357","article-title":"Isolation and detection of human IgA using a streptococcal IgA-binding peptide","volume":"169","author":"Sandin","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-3083.1998.00317.x","article-title":"Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways","volume":"47","author":"Persson","year":"1998","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2004.08.010_bib20","unstructured":"Semmelweis I. Die Aetiologie, der Begriff und die Prophylaxis des Kindbettfiebers (Pest: CA Hartleben), 1861. English translation by Carter KC: The etiology, concept and prophylaxis of chilbedfever, University of Wisconsin Press, 1983."},{"issue":"7","key":"10.1016\/j.vaccine.2004.08.010_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5694\/j.1326-5377.1985.tb123000.x","article-title":"Group A streptococci and puerperal fever. Then and now","volume":"143","author":"Gilbert","year":"1985","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.010_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.61.3.335","article-title":"The serological differentiation of pathogenic and non-pathogenic strains of hemolytic streptococci from parturient women","volume":"61","author":"Lancefield","year":"1935","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.010_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/00222615-39-3-165","article-title":"The serotypes of Streptococcus pyogenes present in Britain during 1990 and their association with disease","volume":"39","author":"Colman","year":"1993","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.08.010_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2958.1999.01470.x","article-title":"The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells","volume":"33","author":"St\u00e5lhammar-Carlemalm","year":"1999","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.08.010_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0966-842X(00)88918-0","article-title":"Epidemic spread and antigenic variability of Neisseria meningitidis","volume":"3","author":"Achtman","year":"1995","journal-title":"Trends Microbiol"},{"issue":"31","key":"10.1016\/j.vaccine.2004.08.010_bib26","doi-asserted-by":"crossref","first-page":"18892","DOI":"10.1074\/jbc.271.31.18892","article-title":"Identification of a family of streptococcal surface proteins with extremely repetitive structure","volume":"271","author":"W\u00e4stfelt","year":"1996","journal-title":"J Biol Chem"},{"issue":"9146","key":"10.1016\/j.vaccine.2004.08.010_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","article-title":"Group B streptococcus","volume":"353","author":"Schuchat","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.010_bib28","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.177.6.1593","article-title":"Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections","volume":"177","author":"St\u00e5lhammar-Carlemalm","year":"1993","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.vaccine.2004.08.010_bib29","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1073\/pnas.89.21.10060","article-title":"Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci","volume":"89","author":"Michel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2004.08.010_bib30","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1128\/IAI.67.12.6350-6357.1999","article-title":"Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V","volume":"67","author":"Areschoug","year":"1999","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2004.08.010_bib31","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.97.17.9630","article-title":"Mosaicism in the alpha-like protein genes of group B streptococci","volume":"97","author":"Lachenauer","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2004.08.010_bib32","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm1202-800","article-title":"An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections","volume":"8","author":"Kotb","year":"2002","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib33","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2004.08.010_bib34","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"Batzloff","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4049\/jimmunol.145.4.1251","article-title":"Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes","volume":"145","author":"Bessen","year":"1990","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.010_bib36","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/IAI.65.6.2080-2087.1997","article-title":"Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus","volume":"65","author":"Ji","year":"1997","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2004.08.010_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI5118","article-title":"New protective antigen of group A streptococci","volume":"103","author":"Dale","year":"1999","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/314655","article-title":"Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI","volume":"179","author":"Guzman","year":"1999","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2004.08.010_bib39","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1128\/IAI.71.9.5097-5103.2003","article-title":"Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci","volume":"71","author":"Courtney","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.010_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/IAI.69.2.924-930.2001","article-title":"Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice","volume":"69","author":"Kawabata","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2004.08.010_bib41","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.4049\/jimmunol.157.11.4935","article-title":"Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site","volume":"157","author":"Accardo","year":"1996","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.08.010_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/IAI.64.2.503-510.1996","article-title":"C5a peptidase alters clearance and trafficking of group A streptococci by infected mice","volume":"64","author":"Ji","year":"1996","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.08.010_bib43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1172\/JCI3065","article-title":"Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection","volume":"102","author":"Ashbaugh","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2004.08.010_bib44","series-title":"The immunoglobulin receptors and their physiological roles in immunity","first-page":"141","article-title":"Cooperation between IgG Fc receptors and complement receptors in host defence","author":"Brown","year":"1998"},{"issue":"6","key":"10.1016\/j.vaccine.2004.08.010_bib45","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/eji.1830210623","article-title":"Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity","volume":"21","author":"Hed\u00e9n","year":"1991","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.08.010_bib46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2958.1991.tb00757.x","article-title":"The IgA-binding b antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions","volume":"5","author":"Jerlstr\u00f6m","year":"1991","journal-title":"Mol Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:30:04Z","timestamp":1682746204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04006127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":46,"alternative-id":["S0264410X04006127"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.08.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}